Search Results - "Wormsley, K G"

Refine Results
  1. 1

    Oncogenes and onco-suppressor gene in adenocarcinoma of the oesophagus by Jankowski, J, Coghill, G, Hopwood, D, Wormsley, K G

    Published in Gut (01-08-1992)
    “…While the activation of the proto-oncogenes has been implicated in the development and progression of cancer of many tissues, the role of oncogenes in the…”
    Get full text
    Journal Article
  2. 2

    Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease by Penston, J G, Wormsley, K G

    Published in Alimentary pharmacology & therapeutics (01-02-1992)
    “…In recent years a number of different strategies for managing patients with peptic ulcer disease have become available. The present review discusses the…”
    Get more information
    Journal Article
  3. 3

    Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis by Jankowski, J, Hopwood, D, Pringle, R, Wormsley, K G

    Published in The American journal of gastroenterology (01-03-1993)
    “…A 49-yr-old male was reviewed who had a 10-yr history of reflux esophagitis. He presented initially with frequent heartburn of moderate severity and, on…”
    Get more information
    Journal Article
  4. 4

    Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression by Jankowski, J, McMenemin, R, Yu, C, Hopwood, D, Wormsley, K G

    Published in Gut (01-05-1992)
    “…This study was designed to correlate mucosal proliferation in Barrett's oesophagus with expression of a growth promoting peptide, transforming growth factor…”
    Get full text
    Journal Article
  5. 5

    Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease by Penston, J G, Wormsley, K G

    Published in Alimentary pharmacology & therapeutics (01-10-1992)
    “…Four hundred and sixty-four patients with duodenal ulcer disease received continuous maintenance treatment with ranitidine for up to 9 years. Treatment failure…”
    Get more information
    Journal Article
  6. 6

    Abnormal expression of growth regulatory factors in Barrett's oesophagus by Jankowski, J, McMenemin, R, Hopwood, D, Penston, J, Wormsley, K G

    Published in Clinical science (1979) (01-11-1991)
    “…1. In order to assess potential abnormalities in the control of mucosal proliferation, 30 patients with Barrett's oesophagus were studied in order to evaluate…”
    Get more information
    Journal Article
  7. 7

    Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine by Hawkey, C J, Long, R G, Bardhan, K D, Wormsley, K G, Cochran, K M, Christian, J, Moules, I K

    Published in Gut (01-10-1993)
    “…The purpose of this study was to compare duodenal ulcer healing, symptom relief, and safety of lansoprazole (a new proton pump inhibitor) given at doses of 30…”
    Get full text
    Journal Article
  8. 8

    Flow-cytometric analysis of growth-regulatory peptides and their receptors in Barrett's oesophagus and oesophageal adenocarcinoma by Jankowski, J, Hopwood, D, Wormsley, K G

    “…The conventional assessment of the premalignant potential of Barrett's oesophagus is unsatisfactory. However, it has recently been shown that abnormalities of…”
    Get more information
    Journal Article
  9. 9

    Epidermal growth factor in the oesophagus by Jankowski, J, Coghill, G, Tregaskis, B, Hopwood, D, Wormsley, K G

    Published in Gut (01-11-1992)
    “…Epidermal growth factor (EGF) has been implicated in mitogenesis and oncogenesis in the gastrointestinal tract. To determine the role of EGF in oesophageal…”
    Get full text
    Journal Article
  10. 10

    The administration of supplementary oxygen to prevent hypoxia during upper alimentary endoscopy by Block, R, Jankowski, J, Johnston, D, Colvin, J R, Wormsley, K G

    Published in Endoscopy (01-05-1993)
    “…A prospective, randomized, controlled trial was conducted in 200 consecutive patients undergoing endoscopy of the upper alimentary tract. One hundred patients…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Rapid healing of gastric ulcers with lansoprazole by Bardhan, K D, Ahlberg, J, Hislop, W S, Lindholmer, C, Long, R G, Morgan, A G, Sjostedt, S, Smith, P M, Stig, R, Wormsley, K G

    Published in Alimentary pharmacology & therapeutics (01-04-1994)
    “…Lansoprazole is a new proton pump inhibitor which powerfully decreases acid secretion. We compared the efficacy and short-term safety of lansoprazole against…”
    Get more information
    Journal Article
  13. 13

    Efficacy and safety of long-term maintenance therapy of duodenal ulcers by Penston, J, Wormsley, K G

    “…The efficacy and safety of continuous (maintenance) treatment with ranitidine has been studied retrospectively in 388 patients with duodenal ulcer. The…”
    Get more information
    Journal Article
  14. 14

    Mallory-Weiss tears occurring during endoscopy: a report of seven cases by Penston, J G, Boyd, E J, Wormsley, K G

    Published in Endoscopy (01-05-1992)
    “…Mallory-Weiss tears occurring during the course of upper gastrointestinal endoscopy are apparently rare. The present report describes seven cases of iatrogenic…”
    Get more information
    Journal Article
  15. 15

    Trends in morbidity and mortality from peptic ulcer disease: Tayside versus Scotland by Penston, J G, Crombie, I K, Waugh, N R, Wormsley, K G

    Published in Alimentary pharmacology & therapeutics (01-08-1993)
    “…Recent studies have shown that the prophylactic use of H2-receptor antagonists reduces both ulcer recurrence and the risk of ulcer complications. Despite these…”
    Get more information
    Journal Article
  16. 16

    Epidermal growth factor receptors in the oesophagus by Jankowski, J, Murphy, S, Coghill, G, Grant, A, Wormsley, K G, Sanders, D S, Kerr, M, Hopwood, D

    Published in Gut (01-04-1992)
    “…The quantity and distribution of epidermal growth factor receptors (EGF-R) in oesophageal mucosa was studied in the oesophagus in order to determine its role…”
    Get full text
    Journal Article
  17. 17

    Pentagastrin increases pepsin secretion without increasing its fractional synthetic rate by Corbett, M E, Boyd, E J, Penston, J G, Wormsley, K G, Watt, P W, Rennie, M J

    Published in The American journal of physiology (01-09-1995)
    “…We studied the effects of increasing doses of pentagastrin on gastric secretion of pepsin and on incorporation of L-[1-13C]leucine into gastric aspirate…”
    Get full text
    Journal Article
  18. 18
  19. 19

    A placebo-controlled investigation of duodenal ulcer recurrence after withdrawal of long-term treatment with ranitidine by Penston, J G, Dixon, J S, Boyd, E J, Wormsley, K G

    Published in Alimentary pharmacology & therapeutics (01-06-1993)
    “…Ninety-two patients with duodenal ulcer disease, who had received long-term continuous treatment with ranitidine for an average of 7.5 years, participated in a…”
    Get more information
    Journal Article
  20. 20

    Safety profile of ranitidine : a review by WORMSLEY, K. G

    Published in Drugs (New York, N.Y.) (01-12-1993)
    “…Ranitidine has been used for the treatment of millions of patients during the past 10 years. A small proportion of patients have developed a reaction to the…”
    Get full text
    Journal Article